A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters

Several COVID-19 vaccines have now been deployed to tackle the SARS-CoV-2 pandemic, most of them based on messenger RNA or adenovirus vectors.The duration of protection afforded by these vaccines is unknown, as well as their capacity to protect from emerging new variants. To provide sufficient cover...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantz, Phanramphoei N., Barinov, Aleksandr, Ruffié, Claude, Combredet, Chantal, Najburg, Valérie, de Melo, Guilherme Dias, Larrous, Florence, Kergoat, Lauriane, Teeravechyan, Samaporn, Jongkaewwattana, Anan, Billon-Denis, Emmanuelle, Tournier, Jean-Nicolas, Prot, Matthieu, Levillayer, Laurine, Conquet, Laurine, Montagutelli, Xavier, Tichit, Magali, Hardy, David, Fernandes, Priyanka, Strick-Marchand, Hélène, Di Santo, James, Simon-Lorière, Etienne, Bourhy, Hervé, Tangy, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560864/
https://www.ncbi.nlm.nih.gov/pubmed/34725327
http://dx.doi.org/10.1038/s41467-021-26506-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560864/
https://www.ncbi.nlm.nih.gov/pubmed/34725327
http://dx.doi.org/10.1038/s41467-021-26506-2

Ejemplares similares